FDA 483 - LC Medical Concepts, Inc - February 25, 2020
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Medical Concepts, Inc. in Rochester, NY, a medical device manufacturer, received a Form FDA 483 citing a repeat observation related to inadequate process validation. The firm failed to adequately validate the sterilization process for its UNI Negative Pressure Wound Therapy Kits. This included not performing required audits and failing to revalidate the process after a previous audit showed positive growth samples, indicating a significant potential risk to product sterility.
ID · dc2047d2-0d5c-4ccd-906d-00a027f71859